Metagenomi Therapeutics: Q4 Earnings Snapshot
0
EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Therapeutics, Inc. (MGX) on Thursday reported a loss of $22.5 million in its fourth quarter.
On a per-share basis, the Emeryville, California-based company said it had a loss of 60 cents.
The genetic medicines company posted revenue of $3.9 million in the period.
For the year, the company reported a loss of $87.9 million, or $2.36 per share. Revenue was reported as $25.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX